Supreme Court Won’t Hear Biolitec-AngioDynamics Case
This article was originally published in The Gray Sheet
Executive Summary
The high court declined to hear arguments in the dispute between Biolitec and AngioDynamics on Nov. 30, leaving Biolitec responsible for damages and contempt of court penalties that could be as high as $160 million.